Regulation of proliferative response of cardiac fibroblasts by transforming growth factor-β1

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 9, 1996, Pages 1921-1929

  Sigel, Andreas V ^a   Centrella, Michael ^a   Eghbali Webb, Mahboubeh ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Differentiation; Extracellular matrix; Heart; Myogenesis; Ventricular hypertrophy cytokines

Indexed keywords

ACTIN; BASIC FIBROBLAST GROWTH FACTOR; DNA; IODINE 125; MESSENGER RNA; MITOGENIC AGENT; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL DENSITY; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; FIBROBLAST; FIBROBLAST CULTURE; GENE EXPRESSION; HEART; ISOTOPE LABELING; MALE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SARCOMERE;

ANIMALIA;

EID: 0030249501     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0185     Document Type: Article

References (34)

1. CENTRELLA M, MCCARTHY TL, CANALIS, E, 1987. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat calvariae. J Biol Chem 262: 2869-2874.
2. CENTRELLA M, HOROWITZ MC, WOZNEY JM, MCCARTHY TL, 1994. Transforming growth factor β (TGF-β) family members and bone. Endocr Rev 15: 27-39.
3. CENTRELLA M, KIM J, PHAM T, CASINGHINO S, ROSEN V, WOZNEY J, MCCARTHY TL, 1995. Independent changes in type I and type II receptors for transforming growth factor β induced by bone morphogenic protein-2 parallel expression of the osteoblast phenotype. Mol Cell Biol 15: 3273-3281.
4. CHEIFETZ S, WEATHERBEE JA, TSANG ML-S, ANDERSON JK, MOLE JE, LUCAS R, MASSAGUE J, 1987. The transforming growth factor-β system, a complex pattern of cross-reactive ligand and receptors. Cell 48: 409-415.
5. CHOMCZYNSKI P, SACCHI N, 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
6. CLEGG CH, LINKHART TA, OLWIN BB, HAUSCKA SD, 1987. Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J Cell Biol 105: 949-956.
7. CLEVELAND DW, LOPATA MA, MACDONALD RJ, COWAN NJ, RUTTER, WJ, KIRSCHNER MW, 1980. Number and evolutionary conservation of α-and β-tubulin and cytoplasmic β-and α-actin genes using specific cloned cDNA probes. Cell 10: 95-105.
8. 1 in the normal rat myocardium. Cell Tissue Res 256: 553-558.
9. EGHBALI M, CZAJA MJ, ZEYDEL M, WEINER FR, ZERN MA, SEIFTER S, BLUMENFELD OO, 1988. Collagen mRNAs in isolated adult heart cells. J Mol Cell Cardiol 20: 267-276.
10. EGHBALI M, TOMEK R, WOODS C, BHAMBI B, 1991 a. Cardiac fibroblasts are predisposed to convert into myocyte phenotype: specific effects of transforming growth factor-beta. Proc Natl Acad Sci USA 88: 795-799.
11. EGHBALI M, TOMEK R, SUKHATME V, WOODS C, BHAMBI B, 1991b. Differential effects of transforming growth factor-β and phorbol mirystate acetate on cardiac fibroblasts: regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ Res 69: 483-490.
12. EGHBALI-WEBB M, 1995. Cardiac fibroblasts. In: Eghbali-Webb M (ed) Molecular Biology of Collagen Matrix in The Heart. R. G. Landes Publishing Company, Austin, Texas (Springer-Verlag) 23-40.
13. ENENSTEIN J, WALEH NS, KRAMER RH, 1992. Basic FGF and TGF-β differentially modulate integrin expression of human microvascular endothelial cells. Exp Cell Res 203: 499-503.
14. EWTON DZ, SPIZZ G, OLSON EN, FLORINI JR, 1988. Decrease in transforming growth factor-β binding and action during differentiation in muscle cells. J Biol Chem 263: 4029-4032.
15. FEINBERG AP, VOGELSTEIN B, 1983. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-13.
16. KARDAMI E, 1990. Stimulation and inhibition of cardiac myocyte proliferation in vitro. Mol Cell Biochem 92: 129-135.
17. LATHROP B, OLSON E, GLASER L, 1985. Control by fibroblast growth factor of differentiation in BC3H1 muscle cell line. J Cell Biol 100: 1540-1547.
18. LEFER AM, TSAO P, AOKI N, PALADINO AM, 1990. Mediation of cardioprotection by transforming growth factor-β. Science 249: 61-64.
19. LONG CS, HENRICH PC, SIMPSON PC, 1991. A growth factor for cardiac myocytes is produced by cardiac nonmyocytes. Cell Regulation 2: 1081-1095.
20. MADRI JA, PRATT BM, TUCKER AM, 1988. Phenotypic modulation of endothelial cells by transforming growth factor-β depends upon the composition and organization of the extracellular matrix. J Cell Biol 106: 1375-1384.
21. MASSAGUE J, CHEIFETZ S, ENDO T, NADAL GINARD B, 1986. Type-β transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci USA 83: 8106-8210.
22. MASSAGUE J, ATTISANO L, WRANA JL, 1994. The TGF-β family and its composite receptors. Trends Cell Biol 4: 172-178.
23. MUKHERJEE D, SEN S, 1991. Alteration of collagen phenotypes in ischemic cardiomyopathy. J Clin Invest 88: 1141-1146.
24. OLSON EN, STERNBERG E, HU JS, SPIZZ G, WILCOX C, 1986. Regulation of myogenic differentiation by type beta transforming growth factor. J Cell Biol 103: 1799-1805.
25. PARKER TG, PACKER ES, SCHNEIDER MD, 1990. Peptide growth factors can provoke fetal contractile protein gene expression in rat cardiac myocytes. J Clin Invest 85: 507-514.
26. PIETENPOL JA, MUNGER K, HOWLEY PM, STEIN RW, MOSES HL, 1991. Factor-binding element in human c-myc promoter involved in transcriptional regulation by transforming growth factor β and by the retinoblastoma gene product. Proc Natl Acad Sci USA 88: 10227-19231.
27. SADOSHIMA J, IZUMO S, 1993. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype. Circ Res 73: 413-423.
28. SANKAR S, MAHOOTI-BROOKS N, CENTRELLA M, MCCARTHY TL, MADRI JA, 1995. Expression of transforming growth factor β type III receptor in bovine endothelial cells increases their responsiveness to transforming growth factor beta. J Biol Chem 270: 13567-13572.
29. SCHORB W, BOOZ GW, DOSTAL DE, CONRAD KM, CHANG KC, BAKER KM, 1993. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 72: 1245-1254.
30. SNOWDEN N, COUPES B, HERRICK A, ILLINGWORTH K, JAYSON MI, BRENCHLEY PE, 1994. Plasma TGF beta in systemic sclerosis: a cross-sectional study. Ann Rheum Dis 53: 763-767.
31. THOMPSON NL, BAZOBERRY F, SPEIR, H, CASSCELLS W, FERRANS VJ, FLANDERS KD, KONDAIAH P, GEISER AG, SPORN MB, 1988. Transforming growth fector-beta in acute myocardial infarction in rats. Growth Factors 1: 91-99.
32. WATSON JD, HOPKINS NH, ROBERTS JW, STEITZ J, WEINER AM, 1987. The control of cell proliferation. In: JD Watson, NH Hopkins, JW Roberts, J Steitz, AM Weiner (eds) Molecular Biology of the Gene. The Benjamin/ Cummings Publishing Company, Inc. Vol 11: 962-1005.
33. WANG X-F, NG-EATON E, DOWNWARD J, LODISH HF, WEINBERG RA, 1991. Expression cloning and characterization of the TGF-β type III receptor. Cell 67: 797-805.
34. YAO J, EGHBALI M, 1992. Decreased collegen gene expression and absence of fibrosis in thyroid hormone-induced myocardial hypertrophy: response of cardiac fibroblasts to thyroid hormone in vitro. Circ Res 71: 831-839.